跳至主要内容
临床试验/NCT06699901
NCT06699901招募中不适用

Antibiotic Concentrations After MassivE Transfusion (ACME) Study

Brooke Army Medical Center2 个研究点 分布在 1 个国家目标入组 417 人开始时间: 2024年9月30日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
417
试验地点
2
主要终点
Amount of drug concentrations within first 18 hours.

研究概览

简要总结

Combat and civilian trauma frequently result in open wounds that are at risk for infection. Data from the Department of Defense Trauma Registry demonstrate that 74% of combat trauma casualties have an open wound. The Committee on Tactical Combat Casualty Care, the Prolonged Field Care Working Group, and the Joint Trauma System clinical practice guidelines recommend antibiotic prophylaxis for open wounds after trauma. The civilian setting has similar risks of open wound infection after trauma. In parallel, current practice guidelines recommend the aggressive use of balanced blood products during resuscitation. It remains unclear how the replacement of blood after hemorrhage through transfusion may affect antibiotic concentrations. Data is necessary to better understand this relationship to enhance wound prophylaxis antibiotic dosing, particularly in severely wounded casualties who receive blood products during massive transfusions. It remains unclear how these resuscitation methods may alter pharmacokinetics. The investigators hypothesize that drug concentrations decrease in direct relation to the amount of blood transfused during low-volume, massive, and supermassive transfusion after trauma compared to patients who receive no blood products. The investigators seek to understand the relationship between drug concentrations and blood product administration using a non-compartmentalized model in the setting of hemorrhage. Specifically, they will (1) obtain drug concentrations at regular intervals during the first 12-18 hours after administration of antibiotics, (2) determine how much blood products and fluids are transfused during the 12 hours prior to antibiotic and 24 hours post-administration, and (3) perform data modeling to understand the relationship between blood transfusions and drug concentrations to inform data-driven dosing models. Liquid chromatography methods will be developed to measure drug concentrations. The investigators will conduct a prospective, multicenter study at two large trauma centers - Brooke Army Medical Center and the University of Colorado Hospital. They will seek to enroll any participant who is hospitalized or anticipated hospital admission for acute trauma and receives an antibiotic on the study list during their index hospitalization. They will then model the drug levels against the amount of blood and fluid infused to create an understanding of the pharmacokinetics of antibiotic wound prophylaxis.

详细描述

This observational study evaluates the impact of blood transfusion volume on antibiotic plasma concentration in trauma patients. Participants who meet trauma criteria in the ED and receive specified antibiotics during their hospitalization are identified through trauma alerts, clinical engagement, and pharmacist involvement. A convenience sample will be enrolled, aiming for a 1:2 ratio of transfused patients to controls. Blood samples (1mL per timepoint) will be taken at six intervals post-antibiotic infusion, often aligning with clinical draws to minimize additional venipunctures. Samples will be processed, stored, and shipped to the USAISR lab for analysis, with data entered into REDCap for de-identified storage and future analysis. Statistical methods include descriptive and inferential statistics, regression modeling, ANOVA, and regression analysis to assess concentration differences by transfusion status and volume. Data is secured under HIPAA regulations, and minimal additional risk qualifies the study for a waiver of informed consent.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Receives ampicillin/sulbactam, cefazolin, cefepime, ceftriaxone, clindamycin, ertapenem, levofloxacin, metronidazole or pipercillin/tazobactam at any dose
  • Hospitalized or anticipated hospital admission

排除标准

  • Received the same antibiotic within the past 5 half-lives of the drug (e.g. received the same antibiotic during a recent interval)
  • <18 years of age
  • Known pregnancy
  • Known Prisoner

结局指标

主要结局

Amount of drug concentrations within first 18 hours.

时间窗: From initial enrollment until 30 days after.

Obtain drug concentrations at regular intervals during the first 18 hours after antibiotic administration.

次要结局

  • Total volume of blood products within 24 hours.(From initial enrollment until 30 days after.)
  • Correlation Between Blood Transfusion Volume and Drug Concentration Levels(Through study completion, an average of 3 years.)

研究者

申办方类型
Fed
责任方
Principal Investigator
主要研究者

Steven Schauer

PRINCIPAL INVESTIGATOR

Brooke Army Medical Center

研究点 (2)

Loading locations...

相似试验